Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord (2010) 2.34

Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology (2010) 2.29

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease. Mov Disord (2011) 2.05

Priorities in Parkinson's disease research. Nat Rev Drug Discov (2011) 1.66

Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease. Mov Disord (2011) 1.57

Non-motor features of Parkinson disease. Nat Rev Neurosci (2017) 1.42

Clinical approach to Parkinson's disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med (2012) 1.30

Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects. Parkinsons Dis (2012) 1.12

Multi-organ autonomic dysfunction in Parkinson disease. Parkinsonism Relat Disord (2010) 1.01

Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected. Pract Neurol (2014) 1.00

Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int (2013) 1.00

Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management. Front Neurol (2012) 0.98

The MDS-UPDRS tracks motor and non-motor improvement due to subthalamic nucleus deep brain stimulation in Parkinson disease. Parkinsonism Relat Disord (2013) 0.95

Treatment of the sleep disorders associated with Parkinson's disease. Neurotherapeutics (2014) 0.95

Management of sexual dysfunction in Parkinson's disease. Ther Adv Neurol Disord (2011) 0.90

Executive dysfunction in Parkinson's disease and timing deficits. Front Integr Neurosci (2013) 0.89

Dopamine-induced nonmotor symptoms of Parkinson's disease. Parkinsons Dis (2011) 0.88

α-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits. Neurobiol Dis (2012) 0.88

Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery? J Neural Transm (Vienna) (2013) 0.84

Urological problems in Parkinson's disease: clinical aspects. J Neural Transm (Vienna) (2012) 0.83

Non-motor symptoms in a Flanders-Belgian population of 215 Parkinson's disease patients as assessed by the Non-Motor Symptoms Questionnaire. Am J Neurodegener Dis (2012) 0.83

The management of orthostatic hypotension in Parkinson's disease. Front Neurol (2013) 0.80

Changes in Olfactory Bulb Volume in Parkinson's Disease: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.79

Apathy in Parkinson's disease is related to executive function, gender and age but not to depression. Front Aging Neurosci (2015) 0.79

Therapeutic options for nocturnal problems in Parkinson's disease and atypical parkinsonian disorders. J Neural Transm (Vienna) (2014) 0.78

Monoamine reuptake inhibitors in Parkinson's disease. Parkinsons Dis (2015) 0.78

Efficacy, safety, and patient preference of monoamine oxidase B inhibitors in the treatment of Parkinson's disease. Patient Prefer Adherence (2011) 0.77

Guidelines for dementia or Parkinson's disease with depression or anxiety: a systematic review. BMC Neurol (2016) 0.77

Nationwide Survey of Patient Knowledge and Attitudes towards Human Experimentation Using Stem Cells or Bee Venom Acupuncture for Parkinson's Disease. J Mov Disord (2014) 0.76

Clinical determinants of primary and secondary fatigue in patients with Parkinson's disease. J Neurol (2013) 0.76

Parkinson disease: treatment of the nonmotor symptoms of Parkinson disease. Nat Rev Neurol (2010) 0.76

Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments. Parkinsons Dis (2016) 0.75

Modafinil: Parkinson disease-related somnolence. Hosp Pharm (2014) 0.75

Fatigue and Muscle Strength Involving Walking Speed in Parkinson's Disease: Insights for Developing Rehabilitation Strategy for PD. Neural Plast (2017) 0.75

Evaluation and management of the non-motor features of Parkinson's disease. Ther Adv Chronic Dis (2011) 0.75

The Treatment of Sleep Disorders in Parkinson's Disease: From Research to Clinical Practice. Front Neurol (2017) 0.75

Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications. P T (2015) 0.75

The Impact of Pallidal and Subthalamic Deep Brain Stimulation on Urologic Function in Parkinson's Disease. Neuromodulation (2016) 0.75

Changing scenario of neuropractice. J Neurosci Rural Pract (2011) 0.75

The role of deep brain stimulation in Parkinson's disease: an overview and update on new developments. Neuropsychiatr Dis Treat (2017) 0.75

Discussing sexuality with patients with Parkinson's disease: a survey among Dutch neurologists. J Neural Transm (Vienna) (2016) 0.75

Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed? J Neural Transm (Vienna) (2012) 0.75

[Nonmotor symptoms in Parkinson's disease]. Nervenarzt (2017) 0.75

Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology (2003) 5.72

Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2006) 5.24

Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med (1999) 4.79

Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology (2003) 4.08

Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology (2005) 3.67

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology (2004) 3.39

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology (2004) 3.34

Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology (2004) 3.27

Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2007) 3.12

Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord (2002) 3.00

Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2006) 2.97

Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2004) 2.93

Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology (2011) 2.91

Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2010) 2.84

Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2002) 2.81

Practice parameter: Assessing patients in a neurology practice for risk of falls (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2008) 2.77

Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2006) 2.77

Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2003) 2.76

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology (2006) 2.70

Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology (2009) 2.58

Environmental risk factors for REM sleep behavior disorder: a multicenter case-control study. Neurology (2012) 2.54

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2009) 2.53

Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet (1995) 2.47

Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2003) 2.35

Pyrethroid and DDT cross-resistance in Aedes aegypti is correlated with novel mutations in the voltage-gated sodium channel gene. Med Vet Entomol (2003) 2.35

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain (2009) 2.35

A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. Neurology (2012) 2.34

Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2006) 2.29

Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology (2010) 2.29

Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms. Eur Respir J (2011) 2.28

Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg (2000) 2.25

Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology (2008) 2.19

Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2005) 2.16

Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology (2008) 2.15

Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2006) 2.12

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2009) 2.08

Evidence-based guideline update: intraoperative spinal monitoring with somatosensory and transcranial electrical motor evoked potentials: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Clinical Neurophysiology Society. Neurology (2012) 2.05

Practice Parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology (2007) 2.04

Severe exacerbation of undiagnosed restless legs syndrome presenting as a movement disorder emergency. Eur J Neurol (2013) 1.97

Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology (2005) 1.97

Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2008) 1.96

Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol (1998) 1.80

Practice parameter: therapies for benign paroxysmal positional vertigo (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2008) 1.76

Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology (2006) 1.72

Practice parameter: Steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 1.71

Pallidal stimulation for Parkinson's disease. Two targets? Neurology (1997) 1.69

The relationship of clinical and academic productivity in a university hospital radiology department. AJR Am J Roentgenol (2000) 1.69

Psychosis as the initial manifestation of adult-onset Niemann-Pick disease type C. Neurology (1995) 1.65

Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord (2001) 1.64

Gait abnormality in essential tremor. Mov Disord (1994) 1.64

Bacterial and fungal oxidation of dibenzofuran. Biochem J (1979) 1.63

Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. Eur J Neurol (2013) 1.61

Retrobulbar anesthesia and retinal vascular obstruction. Ophthalmology (1983) 1.60

Erythropoietin depletion and anaemia in diabetes mellitus. Diabet Med (1999) 1.59

Cognitive impairments associated with early Parkinson's disease. Neurology (1989) 1.59

Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry (1996) 1.58

What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study. Neurology (1997) 1.58

Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry (1999) 1.57

Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol (1999) 1.57

Hemichorea-hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosis. Mov Disord (1989) 1.55

Physiological assessment of aspects of autonomic function in patients with secondary progressive multiple sclerosis. J Neurol (1993) 1.52

Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2004) 1.52

Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol (2001) 1.52

Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory. J Neurol Neurosurg Psychiatry (1988) 1.51

A case of post-traumatic tic disorder. Mov Disord (1989) 1.51

The effect of pregnancy in Parkinson's disease. Mov Disord (2000) 1.51

Survey of training programs' means for promoting neurology and attracting trainees. Neurology (2006) 1.49

Trauma as an etiology of parkinsonism: a historical review of the concept. Mov Disord (1988) 1.49

Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection. Infect Immun (1997) 1.46

Restless legs syndrome. J Neurol Neurosurg Psychiatry (2001) 1.44

Chemical ablation of the gallbladder: is it feasible? J Vasc Interv Radiol (1995) 1.43

Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology (2011) 1.42

Subcutaneous apomorphine in Parkinson's disease. BMJ (1998) 1.41

Amantadine-induced peripheral neuropathy. Neurology (1999) 1.39

Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease. Can J Neurol Sci (2007) 1.39

Transderm-induced psychosis in Parkinson's disease. Neurology (1999) 1.39

Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain (2002) 1.38

Chorea induced by oral contraceptives. Neurology (1979) 1.36

Subcutaneous apomorphine for on-off oscillations in Parkinson's disease. Lancet (1988) 1.35

What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol (1997) 1.35

International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology (2009) 1.34

Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology (1996) 1.32

Sleep disorders and sleep effect in Parkinson's disease. Mov Disord (1990) 1.32

Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology (2009) 1.31

Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology (2000) 1.31

Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med (2013) 1.31

Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy. Neurology (2012) 1.30

Reduced susceptibility to DDT in field populations of Anopheles quadriannulatus and Anopheles arabiensis in Malawi: evidence for larval selection. Med Vet Entomol (2008) 1.29

Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology (2002) 1.28